WallStSmart

Boston Scientific Corp (BSX)vsNortech Systems Incorporated (NSYS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Boston Scientific Corp generates 16744% more annual revenue ($21.00B vs $124.65M). BSX leads profitability with a 17.5% profit margin vs 0.8%. BSX trades at a lower P/E of 17.5x. BSX earns a higher WallStSmart Score of 72/100 (B).

BSX

Strong Buy

72

out of 100

Grade: B

Growth: 7.3Profit: 7.0Value: 6.7Quality: 5.5
Piotroski: 5/9Altman Z: 1.78

NSYS

Hold

37

out of 100

Grade: F

Growth: 3.3Profit: 4.0Value: 4.7Quality: 6.5
Piotroski: 3/9Altman Z: 3.02
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BSXOvervalued (-10.0%)

Margin of Safety

-10.0%

Fair Value

$39.07

Current Price

$45.05

$5.98 premium

UndervaluedFair: $39.07Overvalued

Intrinsic value data unavailable for NSYS.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BSX6 strengths · Avg: 8.2/10
Market CapQuality
$62.29B9/10

Large-cap with strong market position

PEG RatioValuation
0.608/10

Growing faster than its price suggests

P/E RatioValuation
17.5x8/10

Attractively priced relative to earnings

Price/BookValuation
2.6x8/10

Reasonable price relative to book value

Operating MarginProfitability
22.9%8/10

Strong operational efficiency at 22.9%

Free Cash FlowQuality
$1.28B8/10

Generating 1.3B in free cash flow

NSYS2 strengths · Avg: 10.0/10
Price/BookValuation
0.9x10/10

Reasonable price relative to book value

Altman Z-ScoreHealth
3.0210/10

Safe zone — low bankruptcy risk

Areas to Watch

BSX1 concerns · Avg: 4.0/10
Altman Z-ScoreHealth
1.784/10

Distress zone — elevated risk

NSYS4 concerns · Avg: 3.3/10
P/E RatioValuation
32.5x4/10

Premium valuation, high expectations priced in

Market CapQuality
$33.42M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
3.0%3/10

ROE of 3.0% — below average capital efficiency

Profit MarginProfitability
0.8%3/10

0.8% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : BSX

The strongest argument for BSX centers on Market Cap, PEG Ratio, P/E Ratio. Profitability is solid with margins at 17.5% and operating margin at 22.9%. PEG of 0.60 suggests the stock is reasonably priced for its growth.

Bull Case : NSYS

The strongest argument for NSYS centers on Price/Book, Altman Z-Score.

Bear Case : BSX

The primary concerns for BSX are Altman Z-Score.

Bear Case : NSYS

The primary concerns for NSYS are P/E Ratio, Market Cap, Return on Equity. Thin 0.8% margins leave little buffer for downturns.

Key Dynamics to Monitor

BSX profiles as a mature stock while NSYS is a value play — different risk/reward profiles.

BSX carries more volatility with a beta of 0.57 — expect wider price swings.

NSYS is growing revenue faster at 9.3% — sustainability is the question.

BSX generates stronger free cash flow (1.3B), providing more financial flexibility.

Bottom Line

BSX scores higher overall (72/100 vs 37/100), backed by strong 17.5% margins. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Boston Scientific Corp

HEALTHCARE · MEDICAL DEVICES · USA

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

Nortech Systems Incorporated

HEALTHCARE · MEDICAL DEVICES · USA

Nortech Systems Incorporated is an electronic manufacturing services company in the United States, Mexico, and China. The company is headquartered in Maple Grove, Minnesota.

Visit Website →

Want to dig deeper into these stocks?